From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Has Bidstack issued a horrible warning but only for clients of Stifel – does AIM Regulation give a feck as insolvency looms?

By Tom Winnifrith, The Sheriff of AIM | Wednesday 5 May 2021


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


If there is a material change in your trading outlook, as an AIM Company you have a duty to inform the market at once, as per AIM Rules 10 and 11. But if you are Lyin’ James Draper of Bidstack (BIDS) you do not give a flying fuck about the rules. So has he issued a horrible lack of sales/increased losses warning by simply speaking to the analyst at house broker Stifel who slashes forecasts? Is it the case that as of Friday clients of Stifel heard the bad news, other morons who owned the stock did not. And the news, is rumoured to be dire. Cretinous low grade PR firm Buchanan, employers of the journalist smearing fraudsters PR of choice Henry Harrison-Topham, are failing to answer emails or calls on this matter but should get off its fat collective arse and issue an RNS or at least say this is not true if it is not true.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 11:22:07